AAAAAA

   
Results: 1-8 |
Results: 8
Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy
Authors: Broglio, F Benso, A Valetto, MR Gottero, C Quaranta, L Podio, V Arvat, E Bobbio, M Bisi, G Ghigo, E
Citation: F. Broglio et al., Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy, ENDOCRINE, 14(1), 2001, pp. 105-108
The negative GH auto-feedback in childhood: Effects of rhGH and/or GHRH onthe somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue,in children
Authors: Bellone, J Bellone, S Aimaretti, G Valetto, MR Baffoni, C Corneli, G Origlia, C Arvat, E Ghigo, E
Citation: J. Bellone et al., The negative GH auto-feedback in childhood: Effects of rhGH and/or GHRH onthe somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue,in children, J ENDOC INV, 23(3), 2000, pp. 158-162
Technetium-99m labelled macroaggregated albumin arterial catheter perfusion scintigraphy: prediction of gastrointestinal toxicity in hepatic arterialchemotherapy
Authors: Pelosi, E Masaneo, I Clara, R Valetto, MR Bello, M Zanon, C Chiappino, I Grosso, M Mussa, A Bisi, G
Citation: E. Pelosi et al., Technetium-99m labelled macroaggregated albumin arterial catheter perfusion scintigraphy: prediction of gastrointestinal toxicity in hepatic arterialchemotherapy, EUR J NUCL, 27(6), 2000, pp. 668-675
Growth hormone-releasing peptides and the cardiovascular system
Authors: Muccioli, G Broglio, F Valetto, MR Ghe, C Catapano, F Graziani, A Papotti, M Bisi, G Deghenghi, R Ghigo, E
Citation: G. Muccioli et al., Growth hormone-releasing peptides and the cardiovascular system, ANN ENDOCR, 61(1), 2000, pp. 27-31
Acute cardiovascular and hormonal effects of GH and hexarelin, a syntheticGH-releasing peptide, in humans
Authors: Bisi, G Podio, V Valetto, MR Broglio, F Bertuccio, G Del Rio, G Arvat, E Boghen, MF Deghenghi, R Muccioli, G Ong, H Ghigo, E
Citation: G. Bisi et al., Acute cardiovascular and hormonal effects of GH and hexarelin, a syntheticGH-releasing peptide, in humans, J ENDOC INV, 22(4), 1999, pp. 266-272
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans
Authors: Ghigo, E Gianotti, L Arvat, E Ramunni, J Valetto, MR Broglio, F Rolla, M Cavagnini, F Muller, EE
Citation: E. Ghigo et al., Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans, J CLIN END, 84(1), 1999, pp. 285-290
Cardiac effects of hexarelin in hypopituitary adults
Authors: Bisi, G Podio, V Valetto, MR Broglio, F Bertuccio, G Aimaretti, G Pelosi, E Del Rio, G Muccioli, G Ong, H Boghen, MF Deghenghi, R Ghigo, E
Citation: G. Bisi et al., Cardiac effects of hexarelin in hypopituitary adults, EUR J PHARM, 381(1), 1999, pp. 31-38
Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa
Authors: Gianotti, L Rolla, M Arvat, E Belliti, D Valetto, MR Ferdeghini, M Ghigo, E Muller, EE
Citation: L. Gianotti et al., Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa, BIOL PSYCHI, 45(3), 1999, pp. 334-339
Risultati: 1-8 |